Ono Pharmaceutical , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow14.21
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for OPHLY is 14.21. That is below the sector sector average of 27.12. Investors often review this figure alongside Ono Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, OPHLY currently prints 14.21 for P/E ratio, while the sector average sits near 27.12. That is roughly 47.6% below the sector mean. Large gaps often invite a closer look at Ono Pharmaceutical , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of 14.21 for Ono Pharmaceutical , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (27.12) and with OPHLY's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting OPHLY's P/E ratio (14.21), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
